Higher Prevalence and More Severe Coronary Artery Disease in Hepatitis C Virus-infected Patients: A Case Control Study

Journal of Clinical and Experimental Hepatology

Volumn 3, Issue 3, 2013, Pages 186-191

  Satapathy, Sanjaya K ^a,b   Kim, Yun Ju ^a   Kataria, Ashish ^a   Shifteh, Arash ^a   Bhansali, Rohan ^a   Cerulli, Maurice A ^a,b   Bernstein, David ^a,b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

ACE; CAD; Coronary artery disease; DM; HCV; HDL; Hepatitis C; IR; IVDU; LDL; Prevalence

Indexed keywords

ADULT; AGE; ANGIOGRAPHY; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; GENDER; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY;

EID: 84884531555     PISSN: 09736883     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jceh.2013.05.004     Document Type: Article

References (15)

1. Vassalle C., Masini S., Bianchi F., Zucchelli G.C. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart 2004, 90:565-566.
2. Alyan O., Kacmaz F., Ozdemir O., et al. Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system. Circ J 2008, 72:1960-1965.
3. Butt A.A., Xiaoqiang W., Budoff M., Leaf D., Kuller L.H., Justice A.C. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 2009, 15(49):225-232.
4. Arcari C.M., Nelson K.E., Netski D.M., Nieto F.J., Gaydos C.A. No association between hepatitis C virus seropositivity and acute myocardial infarction. Clin Infect Dis 2006, 43:e53-e56.
5. Volzke H., Schwahn C., Wolff B., et al. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis 2004, 174:99-103.
6. Momiyama Y., Ohmori R., Kato R., Taniguchi H., Nakamura H., Ohsuzu F. Lack of any association between persistent hepatitis B or C virus infection and coronary artery disease. Atherosclerosis 2005, 181:211-213.
7. Ishizaka N., Ishizaka Y., Takahashi E., et al. Association between hepatitis C virus seropositivity, carotidartery plaque, and intima-media thickening. Lancet 2002, 359:133-135.
8. Sawayama Y., Okada K., Maeda S., Ohnishi H., Furusyo N., Hayashi J. Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy. Fukuoka Igaku Zasshi 2006, 97:245-255.
9. Fukui M., Kitagawa Y., Nakamura N., Yoshikawa T. Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. JAMA 2003, 289:1245-1246.
10. Sanyal A.J., Contos M.J., Sterling R.K., et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am J Gastroenterol 2003, 98:2064-2071.
11. Sanyal A.J. Review article: non-alcoholic fatty liver disease and hepatitis C-risk factors and clinical implications. Aliment Pharmacol Ther 2005, 22:48-51.
12. Targher G., Bertolini L., Scala L., Zoppini G., Zenari L., Falezza G. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men: role of visceral adipose tissue. Diabet Med 2005, 22:1354-1358.
13. Reardon M.F., Nestel P.J., Craig I.H., Harper R.W. Lipoproteins predictors of the severity of coronary artery disease in men and women. Circulation 1985, 71:881-888.
14. Hung C.H., Lee C.M., Lu S.N. Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications. Expert Rev Anti Infect Ther 2011, 9:525-533.
15. Roed T., Lebech A.M., Kjaer A., Weis N. Hepatitis C virus infection and risk of coronary artery disease: a systematic review of the literature. Clin Physiol Funct Imaging 2012 Nov, 32(6):421-430.